"The Central Georgia Cancer Care team specializes in Hematology and Oncology, offering the latest, most effective, precision treatments personalized for your health issue to safeguard your quality of life. Nationally selected as an Oncology Care Model practice, we are the longest established, most tenured Hematology/Oncology practice in Central Georgia, dedicated to best practices. We partner with research institutions, offering breakthrough therapies right here in Macon and Warner Robins. Each patient encounters an integrated care team including the physician, advanced practice providers and nurses, 24-7 triage, a patient navigator, patient account/assistance representatives, a counselor, pharmacy, lab and CT imaging center."

During the past decade, Central Georgia Cancer Care conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 15 clinical trials were completed, i.e. on average, 214.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Georgia Cancer Care" #1 sponsor was "Accelerated Community Oncology Research Network" with 6 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Vanderbilt-Ingram Cancer Center" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Georgia Cancer Care" #1 collaborator was "Bayer" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Central Georgia Cancer Care" are "Breast Cancer" (5 trials), "Metastatic Breast Cancer" (3 trials), "Neoplasm Metastasis" (2 trials), "Non-small Cell Lung Cancer" (2 trials) and "Pancreatic Cancer" (2 trials). Many other conditions were trialed in "Central Georgia Cancer Care" in a lesser frequency.

Most popular intervention types in "Central Georgia Cancer Care" are "Drug" (36 trials), "Biological" (2 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Docetaxel" (4 trials), "Cyclophosphamide" (3 trials), "Paclitaxel" (3 trials) and "Prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Central Georgia Cancer Care" are 28 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Central Georgia Cancer Care". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Central Georgia Cancer Care, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Central Georgia Cancer Care, 2 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".